Werbung
Werbung

SABS

SABS logo

SAB Biotherapeutics, Inc. Common Stock

3.90
USD
Gesponsert
+0.05
+1.30%
07. Aug., 15:58 UTC -4
Geschlossen
exchange

Nach-Markt

3.87

-0.03
-0.77%

SAB Biotherapeutics, Inc. Common Stock Finanzieller Schnappschuss

Markt Cap
295.92M
Beta
0.53
Gewinn pro Aktie (EPS)
-1.30
Kurs-Buchwert-Verhältnis (P/B)
1.30
Operative Marge
--
Gesamtverschuldung/Eigenkapital (D/E)
1.49%
Kurs-Gewinn-Verhältnis
--
Eigenkapitalrendite (ROE)
-7.05%
Aktuelles Verhältnis
9.22%
Freier Cash Flow
-26.68M
SABS Profil

Ertragsdiagramm

SABSVerdienste

Aktuelle Nachrichten und Prognosen

Alle anzeigen

Aktien im Trend

Space Exploration Technologies Corp. Class A Common Stock logo
Space Exploration Technologies Corp. Class A Common Stock$133.11
+15.83%
Micron Technology, Inc. logo
Micron Technology, Inc.$877.57
-0.44%
Nvidia Corp logo
Nvidia Corp$223.96
+2.27%
Sandisk Corporation Common Stock logo
Sandisk Corporation Common Stock$1,212.21
-3.68%
Microsoft Corp logo
Microsoft Corp$499.99
+0.03%
Palantir Technologies Inc. Class A Common Stock logo
Palantir Technologies Inc. Class A Common Stock$172.01
+10.32%
Tesla, Inc. Common Stock logo
Tesla, Inc. Common Stock$328.58
+2.83%
Werbung